1.Shiozawa A, Szabo SM, Bolzani A, Cheung A, Choi HK: Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review. J Rheumatol 2017, 44(3):388–396.
2.Gustafsson D, Unwin R: The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol 2013, 14:164.
3.Thaikruea L, Thammasarot J: Prevalence of normal weight central obesity among Thai healthcare providers and their association with CVD risk: a cross-sectional study. Sci Rep 2016, 6:37100.
4.Mitsuhashi K, Hashimoto Y, Tanaka M, Toda H, Matsumoto S, Ushigome E, Asano M, Yamazaki M, Oda Y, Fukui M: Combined effect of body mass index and waist-height ratio on incident diabetes; a population based cohort study. J Clin Biochem Nutr 2017, 61(2):118–122.
5.Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F: The concept of normal weight obesity. Prog Cardiovasc Dis 2014, 56(4):426–433.
6.Hsieh SD, Yoshinaga H, Muto T: Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 2003, 27(5):610–616.
7.Nagahama S, Kurotani K, Pham NM, Nanri A, Kuwahara K, Dan M, Nishiwaki Y, Mizoue T: Self-reported eating rate and metabolic syndrome in Japanese people: cross-sectional study. BMJ open 2014, 4(9):e005241.
8.Kuwabara M, Kuwabara R, Niwa K, Hisatome I, Smits G, Roncal-Jimenez CA, MacLean PS, Yracheta JM, Ohno M, Lanaspa MA et al: Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects. Nutrients 2018, 10(8).
9.World Health Organization: Body mass index - BMI. http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi. Accessed 3 Sep 2019.
10.Browning LM, Hsieh SD, Ashwell M: A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutrition research reviews 2010, 23(2):247–269.
11.Owolabi EO, Ter Goon D, Adeniyi OV: Central obesity and normal-weight central obesity among adults attending healthcare facilities in Buffalo City Metropolitan Municipality, South Africa: a cross-sectional study. Journal of health, population, and nutrition 2017, 36(1):54.
12.Yamanaka H: Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides, nucleotides & nucleic acids 2011, 30(12):1018–1029.
13.Kuwabara M, Kuwabara R, Hisatome I, Niwa K, Roncal-Jimenez CA, Bjornstad P, Andres-Hernando A, Sato Y, Jensen T, Garcia G et al: “Metabolically Healthy” Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study. Obesity (Silver Spring, Md) 2017, 25(11):1997–2008.
14.Sonoda H, Takase H, Dohi Y, Kimura G: Uric acid levels predict future development of chronic kidney disease. Am J Nephrol 2011, 33(4):352–357.
15.Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S: Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 2004, 27(4):227–233.
16.Adamopoulos D, Vlassopoulos C, Seitanides B, Contoyiannis P, Vassilopoulos P: The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol (Copenh) 1977, 85(1):198–208.
17.Yahyaoui R, Esteva I, Haro-Mora JJ, Almaraz MC, Morcillo S, Rojo-Martinez G, Martinez J, Gomez-Zumaquero JM, Gonzalez I, Hernando V et al: Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons. J Clin Endocrinol Metab 2008, 93(6):2230–2233.
18.Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M et al: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014, 37(4):253–390.
19.Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M et al: Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan –2012 version. Journal of atherosclerosis and thrombosis 2013, 20(6):517–523.
20.Nanri A, Nakagawa T, Kuwahara K, Yamamoto S, Honda T, Okazaki H, Uehara A, Yamamoto M, Miyamoto T, Kochi T et al: Development of Risk Score for Predicting 3-Year Incidence of Type 2 Diabetes: Japan Epidemiology Collaboration on Occupational Health Study. PLoS One 2015, 10(11):e0142779.
21.Kawasoe S, Kubozono T, Yoshifuku S, Ojima S, Oketani N, Miyata M, Miyahara H, Maenohara S, Ohishi M: Uric Acid Level and Prevalence of Atrial Fibrillation in a Japanese General Population of 285,882. Circ J 2016, 80(12):2453–2459.
22.Yu S, Yang H, Guo X, Zhang X, Zhou Y, Ou Q, Zheng L, Sun Y: Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. Clin Rheumatol 2016, 35(5):1207–1215.
23.Villegas R, Xiang YB, Cai Q, Fazio S, Linton M, Li H, Elasy T, Zheng W, Shu XO: Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men. Metab Syndr Relat Disord 2010, 8(3):263–270.
24.Nakamura K, Sakurai M, Miura K, Morikawa Y, Yoshita K, Ishizaki M, Kido T, Naruse Y, Suwazono Y, Nakagawa H: Alcohol intake and the risk of hyperuricaemia: a 6-year prospective study in Japanese men. Nutr Metab Cardiovasc Dis 2012, 22(11):989–996.
25.Shiraishi H, Une H: The effect of the interaction between obesity and drinking on hyperuricemia in Japanese male office workers. J Epidemiol 2009, 19(1):12–16.